Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa - A marker for poor tumor differentiation, increasing nuclear atypia and invasiveness

Anticancer Research

Volumn 16, Issue 5 B, 1996, Pages 3059-3065

  Lan, Huynh Anh ^a   Zain, Rosnah Binti ^b   Saitoh, Masanori ^c   Muramatsu, Yasunori ^c   Shrestha, Prashanta ^c   Mori, Masahiko ^c  

^a Faculty of Odonto Stomatology   (Viet Nam)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c ASAHI UNIVERSITY   (Japan)

Author keywords

Differentiation; Metastasis; Nuclear atypia; Oral carcinoma; P53; PCNA

Indexed keywords

CYCLINE; PROTEIN P53; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CELL NUCLEUS; CLINICAL ARTICLE; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; EPITHELIUM; HUMANS; HYPERPLASIA; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029818278     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Perrein P: Epidemiologie des cancers buccaux facteurs de risque. Bulletin Officiel de Conscil National les Cancers buccaux 7-23, 1993.
2. Reychler H: Le cancer buccal: clinique, anatoma pathologid et idagnostic. Actualities Odontostomatologizues 180: 669-679, 1992.
3. Bryne M: Prgnostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. J Oral Pathol Med 20: 413-420, 1991.
4. Coltrera MD, Zarbo RJ, Sakar WA, Gown AM: Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53 and CK 19 in alcohol fixed, embedded tissue. Am J Pathol 141: 817-825, 1992.
5. Hall PA, Levison DA: Assessment of cell proliferation in histological material. J Clin Pathol 43: 184-192, 1990.
6. Scott RJ, Hall PA, Haldane JS, Vannorden S, Price Y, Land DP, Wright NA: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165: 173-178, 1991.
7. Scully C, Burkhardt A: Tissue marker of potentially malignant human oral epithelial lesions. J Oral Pathol Med 22: 246-256, 1993.
8. Hall PA, Levison DA, Wood AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
9. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM: Espression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166: 209-219, 1986.
10. Miyauchi K, Fritzler MJ, Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121: 2228-2234, 1978.
11. Morris GF, Mathews MB: Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856-13864, 1989.
12. Jain S, Filipe MI, Hall PA, Lane DP, Levison DA: Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 44: 655-659, 1991.
13. Robbins BA, De La Vega D, Ogata K, Tan EM, Nakamura RM: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 111: 841-845, 1987.
14. Sheneber IF, Shibata HR, Sampalis J, Jothy S: Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71: 1954-1959, 1993.
15. Shrestha P, Yamada K, Wada T, Maeda S, Watatani M, Yasutomi M, Takagi H, Mori M: Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer. Virchows Arch A Pathol Anat 421: 193-202, 1992.
16. Tsuji T, Shrestha P, Yamada K, Takagi H, Shinozaki F, Sasaki K, Maeda K, Mori M: Proliferating cell nuclear antigen in malignant and premalignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study. Virchows Arch A Pathol Anat 420: 377-383, 1992.
17. Yonemura Y, Kimura H, Fushida S, Tsugana K: Analysis of proliferative activity using proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 71: 2448-2453, 1993.
18. Harris AL: Mutant p53- the commonest genetic abnormality in human cancer ? J Pathol 162: 5-6, 1990.
19. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
20. Nigro JM, Baker SJ: Mutations in the p53 gene occur in diverse human tumor types. Nature 342: 705-708, 1989.
21. Oren M: The p53 cellular tumor antigen: gene strucutre, expression and protein properties. Biochem et Biophysica Acta 823: 67-78, 1985.
22. Porter PL, Gown AM, Kramp SG, Coltrera MD: Widespread p53 overexpression in human malignant tumors. An immunlhistochemical study using metharcarn-fixed, embedded tissue. Am J Pathol 140: 145-153, 1992.
23. Yamamoto E, Kohama G, Sunakama H, Iwai M, Hiratsuka H: Mode of invasion of, bleomycin sensitivity and clinical course in squamous cell carcinoma of the oral cavity. Cancer 51: 2175-2180, 1983.
24. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti- PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134: 733-739, 1989.
25. Langdon JD, Partidge M: Expression of the tumour suppressor gene p53 in oral cancer. Br J Cancer 30: 214-220, 1992.
26. Pindborg JJ. Reibel J, Holmstrup P: Subjectivity in evaluating oral epithelia dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 14: 698-708, 1985.
27. Posari S, Roncalli M, Viale G, Bossi P, Coggi G: P53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 169: 425-430, 1993.
28. Joypaul BV, Newman EL, Hopwood D, Grant A, Qureshi S, Lane DP, Crushieri A: Expression of p53 protein in normal, dysplastic and malignant gastric mucosa: an immunohistochemical study. J Pathol 170: 279-283, 1993.
29. Holm R, Skomedal H, Heiland A, Kristensen G, Borresen AL, Nesland JM: Immunohistochemical analysis of p53 protein overexpression in normal, premalignant and malignant tissues of the cervix uteri. J Pathol 169: 21-26, 1993.
30. Ogden GR, Kiddie RA, Conny DP, Lane DP: An assessment of p53 protein expression in normal benign and malignant oral mucosa. J Pathol 166: 389-394, 1992.
31. Purdie CA, Ogrady J, Piris J, Wyllie AH, Bird CC: p53 expression in colorectal tumors. Am J Pathol 138: 807-813, 1991
32. Vamderberg FM, Tigges AJ, Schipper MEI, Den HartogJager FCA, Droes WGM, Wal Boomers JMM: Expression of the nuclear oncogene p53 in colon tumors. J Pathol 157: 193-199, 1989.
33. Warnakulasuriya KAAS, Johnson NW: Expression of p53 mutant nuclear phostphrotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21: 404-408, 1992.
34. Bryne M, Koppang HS, Lillenger R, Kjaerheim A: Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166: 375-381, 1992
35. Start RD, Cross SS, Clelland C, Silcocks PB, Rogers K, Smith JHE: Delay in fixation doesnot affect the immunoreactivity of proliferating cell nuclear antigen (PCNA) J Pathol 68: 197-199, 1992.
36. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM: Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 64: 573-577, 1991.
37. Wynford-Thomas D: p53 in tumor pathology: can we trust immunocytochemistry? J Pathol 166: 329-330, 1992.
38. Niedobite KG, Agatjamggelov A, Barber P, Smallman LA, Jones EL, Young LS: p53 overexpression and Epstein-barr virus injection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 170: 457-461, 1993.
39. Scully C: Oncogenes, onco-suppressor genes, carcinogenesis and oral cancer. Br Dent J 173: 53-59, 1992.